Log on / register
Feedback | Support | My details

Comments

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Marc Tischkowitz email, Jean-Sébastien Brunet email, Louis R Bégin email, David G Huntsman email, Maggie CU Cheang email, Lars A Akslen email, Torsten O Nielsen email and William D Foulkes email

BMC Cancer 2007, 7:134doi:10.1186/1471-2407-7-134

No comments have yet been made on this article

Post a comment


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.